Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
All content for Oncology Unscripted is the property of Katie Coleman, Julie Johnson, Matt Spraker and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker discuss artificial intelligence (AI) in medicine and ChatGPT! We first discuss the software and some other examples of AI in medicine. Then Matt goes head to head against ChatGPT answering questions that Julie or Katie might ask their doctors in the middle of the night. We close with some recommendations on how patients can use ChatGPT to i...
Oncology Unscripted
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
